Looking for leg up in hemophilia B gene therapy race, uniQure flashes data that helped lead to $2B CSL deal

In the two-headed race to develop the first gene therapy for hemophilia B, uniQure just got a major leg up.

In a late-breaking abstract at …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Look­ing for leg up in he­mo­phil­ia B gene ther­a­py race, uniQure flash­es da­ta that helped lead to $2B CSL deal